S49076
S49076 is a novel, potent inhibitor of MET, AXL/MER, and FGFR1/2/3 with IC50 values below 20 nM.
Product Specifications
CAS Number
1265965-22-7
UNSPSC
12352005
Hazard Statement
H302
Target
C-Met/HGFR; FGFR
Type
Reference compound
Related Pathways
Protein Tyrosine Kinase/RTK
Applications
Cancer-Kinase/protease
Field of Research
Cancer
Assay Protocol
https://www.medchemexpress.com/S49076.html
Concentration
10mM
Purity
99.44
Solubility
DMSO : ≥ 31 mg/mL
Smiles
O=C(N1CC2=CC3=C(NC(/C3=C\C4=CC(CN5CCOCC5)=CN4)=O)C=C2)SCC1=O
Molecular Formula
C22H22N4O4S
Molecular Weight
438.50
Precautions
H302
References & Citations
[1]Burbridge MF, et al. S49076 is a novel kinase inhibitor of MET, AXL, and FGFR with strong preclinical activity alone and in association with bevacizumab. Mol Cancer Ther. 2013 Sep;12 (9) :1749-62.
Shipping Conditions
Room Temperature
Storage Conditions
-20°C, 3 years; 4°C, 2 years (Powder)
Scientific Category
Reference compound1
Clinical Information
No Development Reported
Available Sizes
Frequently Asked Questions
More Discoveries
Explore Other Products
Browse additional items from our catalog
BNC400391-500 1x 500 µL
CD81 / TAPA-1 (1.3.3.22), CF640R conjugate, 0.1mg/mL
Sign In for Pricing
View Details 
BNC681688-100 1x 100 µL
CD79a (IGA/1688R), CF568 conjugate, 0.1mg/mL
Sign In for Pricing
View Details 
BNC942227-100 1x 100 µL
GFAP (Astrocyte & Neural Stem Cell Marker) (rASTRO/789), CF594 conjugate, 0.1mg/mL
Sign In for Pricing
View Details 
BNC741071-500 1x 500 µL
Ksp-Cadherin / CDH16 (CDH16/1071), CF740 conjugate, 0.1mg/mL
Sign In for Pricing
View Details 
BNC401149-500 1x 500 µL
CD71 (TFRC/1149), CF640R conjugate, 0.1mg/mL
Sign In for Pricing
View Details